EUVIMEDEUVIMED entdecken
Crossref

Clinical Characteristics and Outcomes of Graves' Disease in Individuals with Prior Hypothyroidism

Afif Nakhleh iD, Eyal Robenshtok iD, Limor Adler iD, Shirley Shapiro Ben David iD, Daniella Rahamim-Cohen iD, Ori Liran, Sagit Zolotov

The Journal of Clinical Endocrinology & Metabolism · 2026

DOI: 10.1210/clinem/dgaf426 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2026. Verfasst von Afif Nakhleh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Diabetes and Endocrinology Clinic, Maccabi Healthcare Services, Haifa 3299001, Israel. Hauptthemen laut MEDLINE: Graves Disease, Hypothyroidism. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Transition from hypothyroidism to Graves' disease (GD) is uncommon.

Objective

To compare presentation, management, and outcomes of GD after hypothyroidism (post-hypo-GD) with GD controls (no prior thyroid disease).

Design

Retrospective cohort 2010 to 2022, followed through October 2024.

Setting

Maccabi Healthcare Services, Israeli health maintenance organization. Patients Adults with incident GD and thyroid-stimulating immunoglobulin activity ≥140% within 1 year of thyrotoxicosis (N = 2402, 256 post-hypo-GD, 2146 GD controls). Excluded prior or current amiodarone users.

Interventions

Longitudinal assessment of usual care with antithyroid drugs, radioactive iodine, or total thyroidectomy, and subsequent hypothyroidism requiring levothyroxine. Main Outcome Measures Usual care treatments and incident hypothyroidism requiring levothyroxine.

Results

Compared to GD controls, post-hypo-GD patients were older (51.4 ± 14.3 vs 47.4 ± 13.6 years, P < .001), predominantly female (88.2% vs 76.9%, P < .001), and with higher prevalence of autoimmune disease (19.5% vs 12.9%, P = .003). At diagnosis, post-hypo-GD patients had milder disease with lower median free T4 (21.7 vs 26.8 pmol/L, P < .001) and free T3 (8.5 vs 10.4 pmol/L, P < .001) levels. Over a 7.2-year median follow-up, post-hypo-GD patients were less frequently treated with antithyroid drugs (65.6% vs 81.0%, P < .001). Radioactive iodine ablation and total thyroidectomy use were comparable. Post-hypo-GD patients were more than twice as likely to develop hypothyroidism requiring levothyroxine at the end of follow-up (41.8% vs 21.0%, P < .001).

Conclusion

Post-hypo-GD (∼10% of new GD cases) is a distinct, predominantly female phenotype marked by milder thyrotoxicosis, lower antithyroid drug use, and a high rate of relapse into hypothyroidism warranting routine assessment of prior thyroid status and close biochemical monitoring.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Graves DiseaseHypothyroidismHumansFemaleMaleMiddle AgedRetrospective StudiesAdultAntithyroid AgentsLongitudinal StudiesThyroidectomyThyroxineFollow-Up StudiesIsraelCase-Control StudiesPrognosisAged

Stichwörter der Autor:innen

Graves' diseaseantithyroid drugshypothyroidismlevothyroxineradioactive iodinetotal thyroidectomy

Substanzen

Antithyroid AgentsThyroxine

Autor:innen und Institutionen

  • Diabetes and Endocrinology Clinic, Maccabi Healthcare Services, Haifa 3299001, Israel.
  • Institute of Endocrinology, Diabetes and Metabolism, Rambam Health Care Campus, Haifa 3109601, Israel.
  • Azrieli Faculty of Medicine, Bar-Ilan University, Safed 1311502, Israel.
  • Endocrinology and Metabolism Institute, Beilinson Hospital, Rabin Medical Center, Petah Tikva 4941492, Israel.
  • Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv 6997801, Israel.
  • Department of Family Medicine, Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv 6997801, Israel.

ORCID-Profile: Afif Nakhleh, Eyal Robenshtok, Limor Adler, Shirley Shapiro Ben David, Daniella Rahamim-Cohen

Zitieren

APA

Nakhleh, A., Robenshtok, E., Adler, L., Shapiro Ben David, S., Rahamim-Cohen, D., Liran, O., & Zolotov, S. (2026). Clinical Characteristics and Outcomes of Graves' Disease in Individuals with Prior Hypothyroidism. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf426

Vancouver

Nakhleh A, Robenshtok E, Adler L, Shapiro Ben David S, Rahamim-Cohen D, Liran O, et al. Clinical Characteristics and Outcomes of Graves' Disease in Individuals with Prior Hypothyroidism. The Journal of Clinical Endocrinology & Metabolism. 2026. doi:10.1210/clinem/dgaf426

BibTeX
@article{Nakhleh2026,
  author = {Nakhleh, Afif and Robenshtok, Eyal and Adler, Limor and Shapiro Ben David, Shirley and Rahamim-Cohen, Daniella and Liran, Ori and Zolotov, Sagit},
  title = {Clinical Characteristics and Outcomes of Graves' Disease in Individuals with Prior Hypothyroidism},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2026},
  doi = {10.1210/clinem/dgaf426}
}
Kostenlos starten →